Tech Company Financing Transactions

Nuvation Bio Funding Round

Nuvation Bio closed a $275 million Series A funding round on 10/30/2019. Backers included Omega Funds, Aisling Capital and Altitude Life Science Ventures.

Transaction Overview

Company Name
Announced On
10/30/2019
Transaction Type
Venture Equity
Amount
$275,000,000
Round
Series A
Investors

Omega Funds (Lead Investor) (Otello Stampacchia)

Aisling Capital

Altitude Life Science Ventures

Boxer Capital

EcoR1 Capital Management

Edbi

Fidelity Management & Research Company

Pavilion Capital Partners

Perceptive Advisors

Redmile Group

Surveyor Capital

The Baupost Group

Proceeds Purpose
The Series A financing will enable Nuvation Bio to expand its development activities and advance a number of its oncology programs.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1500 Bdwy. 1401
New York, NY 10036
USA
Phone
Undisclosed
Email Address
Overview
Nuvation Bio, is a privately-held biopharmaceutical company currently operating in stealth mode that is focused on the development of next generation therapies that will target the foremost unmet needs in oncology. Nuvation Bio's proprietary portfolio includes seven novel and mechanistically distinct oncology programs, each with multiple drug development candidates.
Profile
Nuvation Bio LinkedIn Company Profile
Social Media
Nuvation Bio Company Twitter Account
Company News
Nuvation Bio News
Facebook
Nuvation Bio on Facebook
YouTube
Nuvation Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Hung
  David Hung LinkedIn Profile  David Hung Twitter Account  David Hung News  David Hung on Facebook
Chief Medical Officer
Sergey Yurasov
  Sergey Yurasov LinkedIn Profile  Sergey Yurasov Twitter Account  Sergey Yurasov News  Sergey Yurasov on Facebook
Chief Scientific Officer
Gary Hattersley
  Gary Hattersley LinkedIn Profile  Gary Hattersley Twitter Account  Gary Hattersley News  Gary Hattersley on Facebook
VP - Human Resources
Stacy Markel
  Stacy Markel LinkedIn Profile  Stacy Markel Twitter Account  Stacy Markel News  Stacy Markel on Facebook
VP - Operations
Thomas Templeman
  Thomas Templeman LinkedIn Profile  Thomas Templeman Twitter Account  Thomas Templeman News  Thomas Templeman on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/30/2019: Grax venture capital transaction
Next: 10/30/2019: Socially Determined venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary